COVID-19 fatigue is evident throughout society. Simple quality of life issues such as evening noise from illegal fireworks has been reported in numerous states. For example, the number of illegal fireworks incidents has gone up 300% in Massachusetts according to police data. There are other signs and symptoms of the societal as well as individual toll from the pandemic.

This social and personal "cabin fever" or need to return to a sense of normalcy is not unexpected. Changes in routine, economic challenges and the need for social interaction are part of the human experience. And few times of the year beg for normalcy and freedom of movement than the summer. As clinicians we recognize this. But as health care professionals we must also ask the difficult questions, and sometimes offer the necessary, even if unpopular, guidance. How do we balance the risk with the reward? It is an age old challenge clinicians have faced for centuries.

As someone who has practiced clinical medicine as well as worked in a public health environment on several outbreaks and pandemics, I ask you to consider the following issues, as well as your role in the health of your community.

Is now the right time to try and return to normalcy? Already with the early phasing strategies many states in the US have implemented, there has been a dramatic increase in cases, including Arizona, California, Texas, and Forida, where counties are reporting several health care facilities and ICU\'s are being overwhelmed. Cases are human lives, not sterile statistics. Against this backdrop, when would be a good time for encouraging normalcy, recognizing that suggests restaurants, churches, public events? These are questions a responsible society must ask.

From an infection control perspective, based upon what we know, as well as what we still don\'t fully understand about COVID-19, are we anywhere near "normalcy?" One might suggest the closer we are to an available, effective vaccine, or have determined a significant proportion of our population is known to have immunity against COVID-19, or we can provide some measure of prophylaxis when patients present early in the illness -- that is a good time.

That said, here are thoughts to consider, and some insights for the reader to weigh in on the decisions made in your community.

The practice of medicine, and our ability to deliver timely, appropriate care, even the promotion of programs and policies that can enhance personal and population health is often under the influence of, and may require balancing competing influences. Nowhere does this seem more evident than the current COVID-19 epidemic, with medical and scientific realities, economic imperatives, political objectives, and societal demands each playing a role in decisions that will impact the safety, health, and overall well-being of our populations.

As physicians and healthcare workers it is important to be attuned to the needs of our patients, and the many influencers of health that go beyond pure medical issues. It is no secret to anyone in practice that financial resources plays a role in health, and the COVID-19 pandemic certainly has had a devastating effect on the finances of a significant proportion of our patients; some of which have sustained serious hardship as a result, which may influence their ability to obtain medications and other needed services. This is driving nationwide efforts to reopen businesses and resume some sense of normalcy in terms of commerce across the country.

To be sure the social distancing has also had a negative effect on many patients, as the sense of isolation can contribute to a decline in mental health.

Although these are all important considerations, one has to ask against this backdrop, is it good medical reasoning, or smart public health policy to suggest we are even near a state of "normalcy," notwithstanding using the language of "phased reopening?" As healthcare professionals it is incumbent upon us to be a voice of caution, if not reason, and not just for our patients, giving them good counsel on approaches to maintain their health and safety, but providing our medical expertise for the wider community as well. Given the phased reopening of our communities -- from businesses to beaches, restaurants and other public gatherings, is occurring, we can still be proactive in our guidance, and lend voice for continued precautions.

Especially when you recognize the status of our society in June 2020, compared with March 2020, and ask if we are really near "normalcy" from a medical and public health perspective?

In March 2020 when government policy required most people to essentially shelter in place and self isolate as much as possible, there was a newly discovered coronavirus -- SARS2-COVID-19 emerging as a rapidly spreading respiratory infection with a powerful capacity also to cause extrapulmonary illness, rapid clinical deterioration, even death. It is a pathogen that most of the world\'s population had little immunity against. There were no specific vaccines or antivirals.

Predictably against this backdrop of a highly susceptible population faced with a transmissible virus, COVID-19 spread between 12/19 and 06/20, from a handful of cases to \~7 million worldwide. As a result, social distancing, wearing masks, and essentially closing down much of public life became an essential intervention. These actions allowed the rebuilding of our response infrastructure, hospital capacity, and research efforts to better characterize the virus, identify appropriate, effective interventions, and attempt to develop a safe vaccine. Referred to as "flattening the curve" these infection control measures did in fact slow the spread of COVID-19. These last 2 ½ months allowed some interval successes to be realized.

These successes include many therapeutics identified, and tested as possible interventions for the various stages of COVID-19 illness, as described in this edition. Many vaccine candidates are in various phase trials, some about to enter phase III, and with that advancement comes wider enrollment of participants receiving potentially beneficial vaccination.

Moreover, through great efforts in the clinical/scientific community we have a better understanding of the various mechanisms COVID-19 attacks the body, as well as evades or takes advantage of the immune system, causes some of the profound cascade of symptoms, often serious, that a proportion of patients experience, and even pursuing newer approaches to mitigate those effects. Also better testing is more widely available that can start to provide information about infection penetration in populations, and immune response.

We have made some progress. That is the good news.

Will we lose the gains made during these last two months when increased public gatherings happen? Will we have preparedness amnesia, or a false sense of our ability to respond again? Already many of the emergency facilities which enhanced our health care capacity have been closed, although thankfully some of these locations remain on standby readiness, with equipment still prepositioned to render medical care if needed. It is important to recognize our health care capacity was taxed at the height of the first surge, even with the social distancing practices in place.

Then there is this sobering reminder, as of June 2020, like March 2020 we continue to have a highly susceptible population faced with a transmissible virus. The population still is vulnerable and without well characterized immunity. As discussed earlier, there is the possibility of protective immunity, but how much, how long?

While it is true COVID-19 causes minimal illness for the majority infected, of which many are asymptomatic, which is to say very likely to have beaten the virus, the question of protective immunity has not been fully answered. Does prior infection with COVID-19 or any coronavirus confer immunity, and for how long? The answer is possibly yes, with some lingering and important question marks. This has not changed from March 2020, to June 2020, except the number of patients worldwide who have been already infected.

Add to this, there still is no widely available vaccine. Even with accelerated design and testing strategies, we are at best several months away from having one ready for mass distribution. And with it the persistent question -- if the vaccine works, how long will it work?

And now with the population essentially the same as it was in March 2020, we are facing a phased in approach to "normalcy." Will that lead to an increase in COVID-19 cases? Perhaps even a second surge? Although we have demonstrated an ability to ramp up our capacity to address a surge, can we handle a potentially larger one?

Cold reality -- "normalcy" will not occur until we have a vaccine that is widely delivered to large populations, similar to our ability to deliver over 100,000,000 doses of influenza vaccine annually, or until a significant proportion of our population has well defined immunity to COVID-19, at a level that confers true "herd immunity." And the most rational models base these assumptions on percentage of a population vaccinated, not from prior infection.

Then there is the actual phasing approach, the success of which is based in large measure on human behavior -- will people continue to do what is right? Of all the public health preventive strategies, relying on human behavior is the weakest link. So will people continue to maintain a minimum of 6′ social distancing, and stay masked in public? We are already seeing on a daily basis the answer to that question.

With the obvious reduction in precautions that have occurred over the last few months, can we expect the curve to remain flat with more people interacting? Already much of the public think we are back to normal, or discount the threat COVID-19 actually poses. We need to change their perception. Bringing the public together, and relaxing the precautions from the last 2 ½ months, may provide economic and social benefit, but it is not without medical and public health risk. Our voice of reason can help mitigate some of this risk - reinforcing the use of masks, social distancing, and avoiding crowds, for example.

Unfortunately as Massachusetts and other states enter Phase 3 normalization, with indoor events including restaurants about to be allowed, and the public relaxing protective practices across the country, it should not be a suprirse that the World Health Organization (WHO) on 21 June 2020 announced the largest single day increase in COVID - 10 cases reported (\~183,000). The Americas contributed 116,041, representing the region with the largest increase. In less than a month of relaxing the measures that have led to a flattening of the new case curve, this dramatic increase, which is also being seen in several states in the US, should give us pause and reason to slow the progression to "normal" pre-COVID-19 behaviors.

According to Dr Tedros Adhanom Ghebreyesus, WHO director general who spoke to a conference in Geneva 06/24/20, *"More than 9.1 million cases of Covid-19 have now been reported to WHO, and more than 470,000 deaths.In the first month of this outbreak, less than 10,000 cases were reported to WHO. In the last month, almost four million cases have been reported. We expect to reach a total of 10 million cases within the next week."* Dr. Ghebreyesus goes on to say *"we have an urgent responsibility to do everything we can with the tools we have now to suppress transmission and save lives."*

To be sure, there are several contributing factors to the upsurge in new cases, but one has to acknowledge relaxing the measures that allowed the slowing of new cases has contributed.

It is also worth considering how well we convey as healthcare professionals, administrators, and people in a position to influence policy, decisions that promote good health. Already there is mixed messaging about masks and social distancing. And prior to COVID-19, many healthcare facilities failed to encourage basic infection control practices in general, and especially during prior influenza seasons. Personal protective equipment was not uniformly available, nor was appropriate signage about cough/sneeze etiquette, social distance and reducing germ spread, nor hand sanitizers readily available. Hopefully COVID-19 will have a positive effect on how we educate the public, and promote infection control at our health care facilities in the future.

Outbreaks are predictable occurrences, even though the pathogen may not be. Vaccine rates, infection control, good hygiene, regular education -- within the professions, and involving the public, along with ongoing response drills and practice are essential. As healthcare professionals we need to be engaged in the preparedness process, including greater cooperation with public health, closer collaboration with the media, and the political leadership. This will help avoid delays in policies and response. If there is one thing I learned during the first SARS, avian flu, swine flu and anthrax events - when it hits the fan that is not the tine to exchange business cards or try and become familiar with the many performance cultures needed to effectively engage and contain such threats, and it is not the time to try out preparedness plans to see if they work for the latest threat you face.

What we do today, can set the stage for when the next outbreak occurs in your community.

Health care professionals need to be engaged in the process, to help make certain a viable and effective response will be at the ready. In the interim, our input remains important at all levels of the COVID-19 response.

[^1]: Disclaimer -- Dr. McFee Opinion, not that of elsevier.
